Search details
1.
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy.
BMC Cancer
; 22(1): 1040, 2022 Oct 05.
Article
in English
| MEDLINE | ID: mdl-36195836
2.
Modification of Dargent's radical vaginal trachelectomy to facilitate ureteral dissection: description of technique.
Int J Gynecol Cancer
; 30(8): 1210-1214, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32675055
3.
Comparison of surgical and pathological parameters after laparoscopic transperitoneal pelvic/para-aortic lymphadenectomies.
Int J Gynecol Cancer
; 30(11): 1798-1802, 2020 11.
Article
in English
| MEDLINE | ID: mdl-33037104
4.
A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA).
Anticancer Drugs
; 30(4): 394-401, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30875348
5.
Mesothelin as a target for cervical cancer therapy.
Arch Gynecol Obstet
; 299(1): 211-216, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30324544
6.
Vulvar cancer in Germany: increase in incidence and change in tumour biological characteristics from 1974 to 2013.
Acta Oncol
; 57(3): 324-330, 2018 Mar.
Article
in English
| MEDLINE | ID: mdl-28799431
7.
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study.
Breast Cancer Res Treat
; 161(1): 63-72, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27798749
8.
Intraoperative assessment of margins in breast conservative surgery--still in use?
J Surg Oncol
; 110(1): 15-20, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24863286
9.
Differences in the receptor status between primary and recurrent breast cancer--the frequency of and the reasons for discordance.
Oncology
; 84(6): 319-25, 2013.
Article
in English
| MEDLINE | ID: mdl-23615456
10.
Outcome of early breast cancer treated in an urban and a rural breast cancer unit in Germany.
Onkologie
; 36(9): 477-82, 2013.
Article
in English
| MEDLINE | ID: mdl-24051923
11.
Outcome of immediate re-operation or interval debulking after chemotherapy at a gynecologic oncology center after initially incomplete cytoreduction of advanced ovarian cancer.
Gynecol Oncol
; 126(1): 54-7, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22472462
12.
Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial.
Breast Cancer Res Treat
; 123(2): 437-45, 2010 Sep.
Article
in English
| MEDLINE | ID: mdl-20623180
13.
Abdominal wall metastases in patients with ovarian cancer after laparoscopic surgery: incidence, risk factors, and complications.
Int J Gynecol Cancer
; 20(1): 41-6, 2010 Jan.
Article
in English
| MEDLINE | ID: mdl-20057285
14.
Impact of Nuclear Oestrogen Receptor Beta Expression in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.
Geburtshilfe Frauenheilkd
; 79(10): 1110-1117, 2019 Oct.
Article
in English
| MEDLINE | ID: mdl-31656321
15.
Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018).
Geburtshilfe Frauenheilkd
; 79(10): 1060-1078, 2019 Oct.
Article
in English
| MEDLINE | ID: mdl-31680701
16.
Primary metastatic breast cancer in the era of targeted therapy - Prognostic impact and the role of breast tumour surgery.
Eur J Cancer
; 83: 116-124, 2017 09.
Article
in English
| MEDLINE | ID: mdl-28735068
17.
Diarrhea associated with afatinib: an oral ErbB family blocker.
Expert Rev Anticancer Ther
; 13(6): 729-36, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-23506556
18.
Everolimus as treatment for breast cancer patients with bone metastases only: results of the phase II RADAR study.
J Cancer Res Clin Oncol
; 139(12): 2047-56, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-24072232
19.
Ki67 measured after neoadjuvant chemotherapy for primary breast cancer.
Clin Cancer Res
; 19(16): 4521-31, 2013 Aug 15.
Article
in English
| MEDLINE | ID: mdl-23812670
20.
German adjuvant intergroup node-positive study: a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer.
J Clin Oncol
; 31(28): 3531-9, 2013 Oct 01.
Article
in English
| MEDLINE | ID: mdl-23980081